glp-1 treatment for newly diagnosed diabetes guidelines 2026 Update: ADA vs NICE Diabetes treatment - Gan &

Khan et al., 2024) if nutritional and behavioural supports are not intensified (Sievenpiper 2026)

Since then, others have been made, including: Liraglutide (Victoza for diabetes, Saxenda for weight loss) Dulaglutide (Trulicity), Lixisenatide (Adlyxin) Semaglutide (Ozempic, Wegovy, and Rybelsus, which is a tablet) Tirzepatide (Mounjaro and Zepbound) works on two gut hormones, not just GLP1

The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses

The results from the Boston collaborators raised questions about the physiological way that GLP-1 prompted the release of insulin, a phenomenon described as an 'insulinotropic effect' (Drucker, Philippe, Mojsov)

Syringes and needles Insulin syringes are available at most pharmacies without a prescription in many states